US Broker Ratings

Regencell Bioscience Holdings (RGC) Stock Analysis: Exploring the Volatility and Growth Potential

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a company encapsulated in an intriguing mix of promise and volatility. Operating in the healthcare sector, specifically within the specialty and generic drug..

Repligen Corporation (RGEN) Stock Analysis: Navigating a Potential 61% Upside in the Bioprocessing Space

Repligen Corporation (NASDAQ: RGEN) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Waltham, Massachusetts, Repligen has carved a niche..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring Growth Potential with a Robust 64.87% Return on Equity

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the Healthcare sector, particularly in Diagnostics & Research, continues to capture investor attention with its notable performance metrics and innovative product..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 40% Potential Upside for Investors

Globus Medical, Inc. (NYSE: GMED), a prominent name in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a compelling potential upside of 40.43%. As..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking a 21% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, has increasingly caught the attention of investors seeking opportunities in the medical instruments and supplies industry. With a..

argenx SE (ARGX) Stock Analysis: Exploring a 21.71% Potential Upside Amid Strong Revenue Growth

argenx SE (ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its significant market presence and promising growth prospects. Based in the Netherlands, argenx..

Verona Pharma plc (VRNA) Stock Analysis: Riding High on a 52-Week Surge, But Is the Upside Limited?

Verona Pharma plc (VRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its remarkable price performance over the past year. Headquartered in London, this..

Elanco Animal Health (ELAN) Stock Analysis: Exploring Growth Potential and Investor Ratings

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specializes in the development and marketing of products for pet and farm animal health. With a market..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating a Potential Upside Amidst Healthcare Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the medical devices industry, is drawing attention from investors with its robust market presence and potential for growth within..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A 32.91% Upside Potential Amid Biotech Innovations

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its mission to develop transformative medicines for genetic diseases and cancers. With a market capitalization of $8.9..

Novo Nordisk A/S (NVO) Investor Outlook: Analyzing a 32.82% Potential Upside in the Healthcare Sector

Novo Nordisk A/S (NVO), a Danish pharmaceutical giant, stands as a formidable player in the Healthcare sector, specifically within the drug manufacturing industry. With a commanding market capitalization of $214.43..

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings and 10% Upside Potential

Insmed Incorporated (NASDAQ: INSM) continues to capture investor attention with its robust development pipeline and compelling analyst ratings. Operating in the competitive biotechnology sector, Insmed is at the forefront of..

The Cigna Group (CI) Investor Outlook: Capitalizing on a 33.71% Potential Upside in Healthcare

The Cigna Group (NYSE: CI), a titan in the healthcare sector, stands out not just for its robust market presence but also for its striking potential upside of 33.71%. As..

Amgen Inc. (AMGN) Investor Outlook: Robust Free Cash Flow and a 9.29% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, has consistently demonstrated resilience and innovation within the drug manufacturing industry. With a market capitalization of $155.17 billion, Amgen is..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 20% Potential Upside Amidst Mixed Ratings

Illumina, Inc. (NASDAQ: ILMN), a leading player in the diagnostics and research industry, is currently drawing attention from investors due to its potential upside of 20.05%. Despite facing some challenges,..

DaVita Inc. (DVA) Investor Outlook: Uncovering an 18.53% Upside in the Healthcare Sector

DaVita Inc. (DVA), a prominent player in the healthcare sector, particularly in the realm of medical care facilities, has caught the attention of investors with its solid market position and..

Charles River Laboratories (CRL) Stock Analysis: Navigating a 13.45% Potential Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $7.32 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovation with a 12% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $10.54 billion, this Chicago-based company is..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 69% Upside Potential Beckons Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a renowned name in the biotechnology sector, focusing on the development and commercialization of therapies for rare and life-threatening diseases. With its innovative approach..

Solventum Corporation (SOLV) Stock Analysis: Evaluating an 18% Potential Upside in Healthcare Innovation

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is generating buzz with its unique blend of medical solutions and promising financial metrics. Based in Maplewood, Minnesota, Solventum..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds